Cell Surgical Network and Personal Stem Cell Therapy
Mark Berman
MD, FACS
Elliot Lander
MD, FACS
The Evolution of Cell Surgical Network
Over the years, this work grew to involve multiple clinics and colleagues from across the country and ultimately internationally, all working together under the same standardized IRB-approved protocols, collaborating together and compiling the group’s data in an online HIPAA-compliant database to responsibly advance this new era of medicine, where clinicians can use a patient’s own cells to promote healing within them naturally.
Both Drs. Berman and Lander are conservative physicians, each with over 30 years of surgical experience. Their work with personal adipose derived stem cells, while groundbreaking, still represents a conservative approach to medicine.
Patient safety is critical; using a patient’s cells in a simple surgical procedure mitigates many risks. With more than 15,000 patients in this Stem Cell Revolution, the data continues to support the safety profile of the procedure and personal cell therapy, while the specialists of Cell Surgical Network keep expanding the frontiers of regenerative medicine with optimal cell deployment strategies and approaches.
What Sets CSN’s Stem Cell Therapy Apart
Personal Cell Therapy. Mother nature designed your own stem cells to heal you. CSN’s technology takes advantage of this to promote healing in our patients naturally with the help of their own stem cells containing their own DNA from their own adipose tissue.
Autologous Adipose-Derived SVF
Stromal Vascular Fraction (SVF) is a mix of mesenchymal stem cells (MSCs), hematopoietic stem cells (HSCs), pericytes, pre-adipocytes, white blood cells, red blood cells and growth factors (cytokines). The first four cell types are all considered progenitor or stem cells because they have the ability to differentiate into other cell types, self-replicate, donate healthy mitochondria to unhealthy cells, or send cellular signals to other cells via the paracrine effect.
Your Youngest Cells
Coming from adipose tissue, SVF generally happens to be an incredibly young and robust source of stem cells. The average lifespan of a fat cell is 7 to 10 years. Thus, the stem cells in your fat only have to work once every 7 to 10 years. Compared to other stem cells in your body that support your lungs or immune system that are likely working daily, adipose derived stem cells are relatively dormant and sequestered from the rest of the body, making them relatively much younger than your other cells, something that has been confirmed repeatedly through telomere analysis.
Simple. Safe. Surgical. Automated.
CSN’s surgical procedure to harvest and isolate SVF has never been easier and more efficient than with the Time Machine 3.0 Auto. The procedure is all done under local anesthesia and only requires a 50cc lipoaspirate. The SVF is automatically isolated from the adipose tissue in a closed system, making it safe and convenient for the surgical staff.
Investigational Therapy and IRB Approval
CSN has developed numerous protocols that have received IRB approval, many of which have resulted in leading peer-reviewed publications.
These include but are not limited to:
- SVF for Knee Arthritis, reporting on over 2500 patients
- SVF for Lumbar Spine Disease, reporting on over 500 patients
- Safety of SVF, reporting on over 1500 patients receiving IV infusion of cells
- Application of SVF for Interstitial Cystitis
- SVF and Personal Cell Therapy for Neurodegenerative Diseases
Since SVF and personal cell therapy can be applied in many specialties, our multidisciplinary organization works with many physicians interested in conducting their own single and multi-clinic trials and can help facilitate the application of your own protocol for IRB review to help safely and effectively advance this new era of medicine.
Multidisciplinary Approach
Since our bodies are made up of nothing but cells, it’s conceivable that stem cells could and should be used throughout medicine. CSN believes that personal cell therapy should be a critical tool in every physician’s toolbelt and that the best care is provided by specialists. Thus, CSN encourages a multidisciplinary approach to regenerative medicine for the best care patients can get.
Are All Stem Cell Treatment Centers the Same?
Cell Surgical Network
- Personal Cell Therapy (no risk of rejection or disease transmission)
- Be part of the network that secured regulatory protection for personal cell therapy
- Practice under the Same Surgical Exemption
- Data Driven based on HIPAA Compliant database
- Automated long-term patient follow ups
- Collect and publish peer-reviewed data
Other Clinics
- Allogeneic products (risk of rejection and disease transmission)
- Unsubstantiated claims and testimonials
- Dubious cell quality: amniotic, allogenic, “light” activated etc.
- No protocols, just sales of machines or weekend courses
- No significant support once supplies are paid for
- No data collection & Little ongoing education
Cell Surgical Network
Cell Surgical Network is at the forefront of regenerative medicine, providing cutting-edge technology for doctors interested in harnessing the potential of a patient’s own stem cells. With a strong emphasis on safety and efficacy, their collaborative approach and IRB-approved protocols empower physicians to offer personalized cell therapies and explore the latest advancements in regenerative medicine.
Our Network Member
We have Member across the globe, which includes:
500
Doctors
125
Locations
15,000
Procedures
Sharing Data
All CSN members use Regenatrak, an online HIPAA-compliant database, to evaluate all patients seen in the network. Regenatrak allows a physician to input patients’ condition-specific baselines and details from their procedure op notes and then follow up with their patients automatically and periodically for a 5-year period, tracking safety and efficacy.
The data is shared amongst the network and helps drive decision-making when determining each procedure’s best approach and effectiveness. This transparent patient feedback is the best tool for advancing personal cell therapy.
Experiences for Scientific Advancement
CSN provides physicians and clinics with a turnkey, safe, effective, and legal solution to providing your patients with personal cell therapy. Our techniques and equipment have been refined by industry-leading medical experts for well over a decade. We rely on an international database that follows up with all of our patients to track safety and efficacy to methodically advance our precision personalized medicine and offer the best potential outcomes to patients.
Patient Experience and Inquiries
Cell Surgical Network is at the forefront of regenerative medicine, providing cutting-edge technology for doctors interested in harnessing the potential of a patient’s own stem cells. With a strong emphasis on safety and efficacy, their collaborative approach and IRB-approved protocols empower physicians to offer personalized cell therapies and explore the latest advancements in regenerative medicine.
Access to Investigational Therapy
Access to personal cell therapy with autologous SVF is a paradigm shift in medicine, away from traditional surgeries, which can be invasive and risk serious morbidity and even mortality, to a natural way of promoting healing. Our patients’ own personal cells will not be rejected as they are their own and their innate properties are potentially the perfect tool when looking to restore aging degenerative tissue.
Online Resources and Information
With more than 15,000 patients in this Stem Cell Revolution, the data continues to support the safety profile of the procedure and personal cell therapy, while the specialists of Cell Surgical Network keep expanding the frontiers of regenerative medicine with optimal cell deployment strategies and approaches.
Contacting Network Member
If you’re interested in connecting with one of Cell Surgical Network’s specialized physicians to see if personal cell therapy might be a good option for you, please fill out this form and we would be happy to direct you appropriately.
Our Commitment to Research and Advancement
CSN has over 13 peer-reviewed publications to date, many of the largest of their kind. Our network and the physicians we work with are committed to long-term patient outcomes, so we track all our patients in the Regenatrak database.
CSN also helps to support not only research into personal cell therapy and SVF but the rest of the regenerative medical field by helping to sponsor the annual Cell Surgical Conference, a CME event that brings together the leading physicians, scientists, and innovators for a multiday symposium, educating on the latest advancements.
Conclusion
The future of medicine is here today, and it’s based on the principles of the past. We’re using what Mother Nature gave us, our own stem cells, to help promote healing in ways that traditional surgery and pharmaceuticals might not be able to accomplish and witnessing a paradigm shift in medicine. Welcome to the future. Welcome to the Stem Cell Revolution.